Parsidol monohydrochloride
Brand names,
Parsidol monohydrochloride
Analogs
Parsidol monohydrochloride
Brand Names Mixture
Parsidol monohydrochloride
Chemical_Formula
C19H24N2S
Parsidol monohydrochloride
RX_link
No information avaliable
Parsidol monohydrochloride
fda sheet
Parsidol monohydrochloride
msds (material safety sheet)
Parsidol monohydrochloride
Synthesis Reference
No information avaliable
Parsidol monohydrochloride
Molecular Weight
312.473 g/mol
Parsidol monohydrochloride
Melting Point
64.5 oC
Parsidol monohydrochloride
H2O Solubility
0.693 mg/L
Parsidol monohydrochloride
State
Solid
Parsidol monohydrochloride
LogP
5.772
Parsidol monohydrochloride
Dosage Forms
Tablet (10 mg); Tablet (scored, 50 mg)
Parsidol monohydrochloride
Indication
For use in the treatment of Parkinson's disease and also used to control severe reactions to certain medicines such as reserpine.
Parsidol monohydrochloride
Pharmacology
Ethopropazine, a phenothiazine and antidyskinetic, is used in the treatment of Parkinson's disease. By improving muscle control and reducing stiffness, this drug permits more normal movements of the body as the disease symptoms are reduced. It is also used to control severe reactions to certain medicines such as reserpine, phenothiazines, chlorprothixene, thiothixene, loxapine, and haloperidol. Unlike other NMDA antagonists, ethopropazine — because of its anticholinergic action — is largely devoid of neurotoxic side effects. Ethopropazine also has a slight antihistaminic and local anesthetic effect.
Parsidol monohydrochloride
Absorption
Well-absorbed from the gastrointestinal tract.
Parsidol monohydrochloride
side effects and Toxicity
Symptoms of overdose include severe clumsiness or unsteadiness, severe drowsiness, severe dryness of mouth, nose, or throat, fast heartbeat, shortness of breath or troubled breathing, and warmth, dryness, and flushing of skin.
Parsidol monohydrochloride
Patient Information
Parsidol monohydrochloride
Organisms Affected
Humans and other mammals